Résultats de la recherche

search
logo.png
Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company’s Proprietary Catheter-Based Technology
30 déc. 2024 08h30 HE | Autonomix Medical, Inc.
Growing global patent portfolio to over 120 patents with 80 issued patents and over 40 pending patent applications Previously completed preclinical study evaluating targeted nerve ablation...
logo.png
Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain
16 avr. 2024 09h00 HE | Autonomix Medical, Inc.
Patent portfolio with over 100 patents, issued and pending, protects technology targeting a $100 billion market opportunity Company developing potential breakthrough two-fold technology that can...
Kalos 2 (1).jpg
Correction -- Kalos Medical, Inc.
09 mai 2023 21h56 HE | Kalos Medical Inc.
SEOUL, South Korea, May 09, 2023 (GLOBE NEWSWIRE) -- In a release issued on Wednesday, May 3rd by Kalos Medical, Inc., please note that a revised title is being used. The corrected release follows: ...
Kalos 2 (1).jpg
Kalos Medical Announces Grant Award, Completion of Patient Recruitment of Clinical Trial
03 mai 2023 08h00 HE | Kalos Medical Inc.
SEOUL, South Korea, May 03, 2023 (GLOBE NEWSWIRE) -- Kalos Medical, Inc. (“Kalos”), a developer of innovative and minimally invasive medical devices using proprietary catheter-based technology,...